JAMIE BORNER: Open Payments
NPI 1134630254 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 30 payments from 9 companies in 2025. Trend: 2023 $736 · 2024 $533 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 3 | $259 |
| Astellas Pharma US Inc | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $85 |
| Evofem Biosciences, Inc. | 9 | $54 |
| MILLICENT US INC | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Exact Sciences Corporation | 1 | $28 |
| Organon LLC | 1 | $22 |
| CooperSurgical, Inc. | 1 | $22 |
Products named: ANNOVERA, Veozah, Phexxi, Mirena, FEMRING, MYFEMBREE, Lynkuet, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
